Published on 17 Apr 2024 on Investing.com
Sage Therapeutics reports setback in Parkinson's study By Investing.com
Sage Therapeutics, Inc. (NASDAQ: SAGE), a biopharmaceutical company, disclosed today that its Phase...
NASDAQ.SAGE price evolution
Want to become a better investor?
Start tracking your investments with Statfolio
Sign up for free